Article
Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach.
Anticancer research - 1 Apr 2014
Ribeiro Flávia Andressa Pidone, Noguti Juliana, Oshima Celina Tizuko Fujiyama, Ribeiro Daniel Araki
Abstract excerpt
Oral cancer is a serious problem growing in incidence in many parts of the world; it is considered the sixth most common cancer and despite sophisticated surgical and radiotherapeutic modalities, oral squamous cell carcinoma, which represents 90% of oral cancers, is characterized by poor prognosis and a low survival rate. The Epidermal growth factor receptor family of receptor tyrosine kinases (RTK) comprises of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
